Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma

Clinical trial NCT03281551 · UNKNOWN

Trial details

NCT number: NCT03281551
Sponsor: Pinze Lifetechnology Co. Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia B-cell Lymphoma

Start date: 2017-10-01
Primary completion: 2020-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.